CLDN3 and hepatocellular carcinoma: Since intra-hepatic metastases are a major hallmark of metastatic HCC contributing to dismal long-term survival in HCC patients [47], [48], how rVP1 interferes with the metastasis of HCC and its potential application in anti-metastasis therapy is worth further investigation.